Howard Allan Simon

Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.

InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA.

ABD Insurance & Financial Services, Inc. (ABD) provides insurance brokerage, employee benefits consulting and risk management solutions to clients across the United States and around the world. ABD has 17 regional business centers across the western United States. ABD is a subsidiary of Greater Bay Bancorp, a financial services holding company. The company is located in Redwood City, CA.

Breathe California, Golden Gate Public Health Partnership offers local services that address lung health issues. This includes programs to: help kids manage their asthma, prevent teens from using tobacco, assist smokers who want to quit, and offer support to emphysema and lung cancer patients. The firm also advocates for key clean air and public health policies, and support innovative lung health research. The company was founded in 1908 and is headquartered in San Francisco, CA.

DNA TwoPointO, Inc. provides bioengineering solutions. It offers an integrated pipeline of solutions for the research community including platforms for protein and vector engineering, products such as expression vectors, fluorescent and chromogenic proteins, cell strains and reagents, as well as gene design, optimization and cloning. The company was founded in 2003 and is headquartered in Newark, CA.